Skip to main content
Clinical Trials/JPRN-jRCTs032210411
JPRN-jRCTs032210411
Recruiting
Phase 2

Multicenter study to evaluate glaucoma detection ability by new visual field test program (SITA Standard 24-2C)

akano Tadashi0 sites50 target enrollmentNovember 5, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Glaucoma or suspected glaucoma
Sponsor
akano Tadashi
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 5, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
akano Tadashi

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with glaucoma or suspected glaucoma on regular visits to the hospital
  • 2\) Patients with or without treatment.
  • 3\) Patients who have previously undergone HFA visual field testing (SITA Standard 24\-2 program) and have an MD of \-25D or higher and corrected visual acuity of 0\.5 or higher
  • (4\) Age: Those who are 20 years old or older at the time of obtaining consent.
  • 5\) Gender: Any.
  • (6\) Those who have received sufficient explanations about participation in this study, and have given written consent of their own free will with sufficient understanding.
  • (7\) Those who are able to attend outpatient clinics according to the research implementation schedule

Exclusion Criteria

  • 1\) Patients who did not give consent to participate in this study
  • 2\) Eyes with ocular findings that affect the visual field other than glaucoma, or eyes that have previously undergone internal eye surgery other than cataract or glaucoma
  • 3\) Other patients who are judged by the principal investigator to be inappropriate for participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials